Skorpios Trust - 22 Aug 2025 SCHEDULE 13D/A Report for Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK)

Filing Manager
Skorpios Trust
Reporting Manager
Montrago Trustees Ltd
Security
Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
STOK
Shares outstanding
55,028,805 shares
Disclosed Ownership
2,256,181 shares
Ownership
4.1%
Form type
SCHEDULE 13D/A
Filing time
26 Aug 2025, 17:42:26 UTC
Date of event
22 Aug 2025
Previous filing
23 Jun 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Skorpios Trust disclosed 4.1% ownership in Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK) on 22 Aug 2025."

Quick Takeaways

  • Skorpios Trust filed SCHEDULE 13D/A for Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK).
  • Disclosed ownership: 4.1%.
  • Date of event: 22 Aug 2025.

What Changed

  • Previous schedule filing date: 23 Jun 2025.
  • Current filing was accepted on 26 Aug 2025, 17:42.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Blue Horizon Enterprise Ltd 3.6% 1,967,621 0 1,967,621 /s/ Eleni Constantinou Kyriacou Eleni Constantinou Kyriacou, Director 0001869057
Ezbon International Ltd 0.5% 288,560 0 288,560 /s/ Eleni Constantinou Kyriacou Eleni Constantinou Kyriacou, Director 0001869027
Montrago Trustees Ltd 4.1% 2,256,181 0 2,256,181 /s/ Androulla Papadopoulou Androulla Papadopoulou, Director 0001869331
Skorpios Trust 4.1% 2,256,181 0 2,256,181 /s/ Androulla Papadopoulou Androulla Papadopoulou, Director 0001869333

Sponsored